Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-10-19
1989-05-02
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514285, 546 61, 546 62, C07D22104, C07D491048, C07D49504, A61K 3147
Patent
active
048268500
ABSTRACT:
The present invention provides a quinoline base compound represented by the following general formula (1) of: ##STR1## wherein X is CH.sub.2, O or S. Further provided are the process for the preparation of the aforementioned quinoline base compound and an anticancer agent including the same as a pharmacologically efficacious component.
REFERENCES:
Dzieworski et al., Chem. Abstracts, vol. 59 (1963), entry 11365d.
G. J. Atwell et al., Journal of Medicinal Chemistry, 1972, vol. 15, No. 6, pp. 611-615.
Bruce F. Cain et al., Journal of Medicinal Chemistry, 1974, vol. 17, No. 9, pp. 922-930.
Bruce F. Cain et al., Journal of Medicinal Chemistry, 1975, vol. 18, No. 11, pp. 1110-1117.
David A. Van Echo et al., Cancer Research 39, 3881-3884, Oct. 1979.
Gerstl Robert
Mect Corporation
Rozycki Andrew G.
LandOfFree
Quinoline base compound, process for the preparation thereof and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline base compound, process for the preparation thereof and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline base compound, process for the preparation thereof and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-585218